Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet P-J, Zuberbier T, Demoly P, Canonica G W
Allergy & Respiratory Diseases, DIMI - University of Genoa, Genoa, Italy.
Allergy. 2008 Jun;63(6):660-9. doi: 10.1111/j.1398-9995.2008.01649.x.
Allergic diseases constitute a global health problem, as they have an increasing economic and social impact and, especially, they can deeply interfere with the patients' daily life, being a cause of physical and emotional discomfort. This is why the health-related quality-of-life (HRQoL) has become increasingly important in health care research; in fact, the assessment of the impact the disease and its treatment have on patients, provides a more comprehensive approach in outcome evaluation. Numerous validated questionnaires are available and many studies have been performed evaluating HRQoL in people affected by allergic rhinitis (AR), thus testifying a great interest in this topic. The aims of the present review are: to examine the scientific literature of the last 3 years dealing with the impact of AR treatments suggested by allergic rhinitis and its impact on asthma guidelines on patients' QoL, and to identify the unexplored or not-fully-investigated areas concerning this issue.
过敏性疾病构成了一个全球性的健康问题，因为它们对经济和社会的影响日益增加，尤其是它们会严重干扰患者的日常生活，成为身体和情绪不适的一个原因。这就是为什么与健康相关的生活质量（HRQoL）在医疗保健研究中变得越来越重要；事实上，评估疾病及其治疗对患者的影响，在结果评估中提供了一种更全面的方法。有许多经过验证的问卷，并且已经进行了许多研究来评估过敏性鼻炎（AR）患者的HRQoL，从而证明了对这个主题的极大兴趣。本综述的目的是：审查过去3年中关于过敏性鼻炎指南建议的AR治疗对患者生活质量的影响及其对哮喘的影响的科学文献，并确定关于这个问题的未探索或未充分研究的领域。
